Final answer:
Dispensers must submit detailed records including patient information and details of the controlled substance dispensed to prescription monitoring programs to prevent misuse and ensure safety.
Step-by-step explanation:
Dispensers in prescription monitoring programs must submit specific information for each controlled substance or monitored drug. This information typically includes the patient's identification, the drug dispensed, the quantity and date of dispensation, and the prescribing healthcare provider.
The objective is to monitor and prevent the misuse of controlled substances, such as opiates and prescription pain relievers like Oxycodone and Fentanyl. In addition to tracking dispensation, pharmaceutical companies must also monitor the safety and efficacy of their products post-approval, reporting any adverse events to the FDA on a scheduled basis or upon immediate discovery of serious or fatal outcomes. The process is part of a larger regulatory framework to ensure drugs are safely managed throughout their lifecycle.